Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 59.75
+0.75 (1.27%)
Nov 4, 2026, 5:29 PM CET
STO:SUS Market Cap
STO:SUS has a market cap or net worth of 3.05 billion as of November 4, 2026. It is the 17,685th most valuable company in the world and the 226th biggest in Sweden. Its market cap has decreased by 27.58% in one year.
Market Cap
3.05B
Enterprise Value
2.39B
Revenue
1.02B
Global Rank
Country Rank
#226 Sweden
PE Ratio
32.83
ChartMarket Cap Chart
Since June 19, 2017, STO:SUS's market cap has increased from 279.67M to 3.05B, an increase of 990.13%. That is a compound annual growth rate of 28.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 3.05B | 83.85% |
| Dec 30, 2025 | 1.66B | -79.15% |
| Dec 30, 2024 | 7.95B | -14.58% |
| Dec 29, 2023 | 9.31B | 11.30% |
| Dec 30, 2022 | 8.37B | -41.49% |
| Dec 30, 2021 | 14.30B | 343.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 166.76B |
| Getinge AB | 74.44B |
| Sectra AB | 63.70B |
| Medicover AB | 42.55B |
| Egetis Therapeutics AB | 4.63B |
| CellaVision AB | 4.57B |
| Hansa Biopharma AB | 3.85B |
| Vicore Pharma Holding AB | 2.67B |